ZL-N-91

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameZL-N-91
Drug Alias NamePDE4 inhibitor (Guangzhou Sinogen Pharmaceutical/Zhejiang University)ZL-N-91
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitorsInterleukin-17 inhibitors
TargetsInterleukin-17Phosphodieterase 4
Therapy Area/IndicationsInflammationAutoimmune DiseasesPulmonary Disease, Chronic Obstructive +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesZhejiang University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGuangzhou Sinogen Pharmaceutical Co LtdZhejiang University
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune DiseasesPulmonary Disease, Chronic Obstructive +[5] 

Other Information

ATC CodeN/A
Related LinksN/A